METHYL-Beta-ORCINOLCARBOXYLATE FROM LICHEN (EVERNIASTRUM CIRRHATUM) FOR USE FOR THE TREATMENT OF FUNGAL INFECTIONS AND CANCER

摘要

The present invention relates to the new use of an already known biomolecule methyl- b -orcinol carboxylate of formula (I) isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B, nystatin, clotrimazole etc.